IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

(2021) Hervé Tilly et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

(2020) George W. Wright et al.   CANCER CELL

Antibody-secreting cell destiny emerges during the initial stages of B-cell activation

(2020) Christopher D. Scharer et al.   Nature Communications

Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma

(2020) Thomas A Ollila et al.   BLOOD

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

(2019) C. Soussain et al.   EUROPEAN JOURNAL OF CANCER

Prognostic significance of monoclonal gammopathy in diffuse large B‐cell lymphoma

(2019) Sotirios G. Papageorgiou et al.   HEMATOLOGICAL ONCOLOGY

The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL)

(2019) Elena Maiolo et al.   LEUKEMIA & LYMPHOMA

Synergistic cooperation and crosstalk between MYD88 L265P and mutations that dysregulate CD79B and surface IgM

(2017) James Q. Wang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Clinicopathologic Characterization of Diffuse-Large-B-Cell Lymphoma with an Associated Serum Monoclonal IgM Component

(2014) M. Christina Cox et al.   PLoS One

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma

(2013) Fabrice Jardin et al.   LEUKEMIA & LYMPHOMA

Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?

(2011) Maria Christina Cox et al.   AMERICAN JOURNAL OF HEMATOLOGY

Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma

(2011) Matthew J. Maurer et al.   JOURNAL OF CLINICAL ONCOLOGY